Rapport Therapeutics (RAPP) Prepaid Assets (2023 - 2026)
Rapport Therapeutics (RAPP) reported Prepaid Assets of $7.8 million for Q1 2026, up 41.4% year-over-year from $5.5 million in Q1 2025, and down 2.11% quarter-over-quarter from $7.9 million in Q4 2025.
Rapport Therapeutics (RAPP) Prepaid Assets (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Prepaid Assets data on file, last reported at $7.8 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $7.8 million, up 41.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (up 41.4% YoY), and the FY2025 annual result was $7.9 million, up 79.24% from the prior year.
- Prepaid Assets slipped to $7.8 million in Q1 2026 per RAPP's latest filing, from $7.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $9.7 million in Q2 2025 and troughed at $1.5 million in Q4 2023.
- A 4-year average of $6.0 million and a median of $5.5 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2026: Prepaid Assets surged 194.47% in 2024, then jumped 41.4% in 2026.
- A 4-year view of Prepaid Assets shows it stood at $1.5 million in 2023, then surged by 194.47% to $4.4 million in 2024, then surged by 79.24% to $7.9 million in 2025, then fell by 2.11% to $7.8 million in 2026.
- Business Quant data shows RAPP's Prepaid Assets at $7.8 million in Q1 2026, $7.9 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.75 Mn |
| Dec 31, 2025 | 7.92 Mn |
| Sep 30, 2025 | 7.53 Mn |
| Jun 30, 2025 | 9.69 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 4.42 Mn |
| Dec 31, 2023 | 1.50 Mn |